Zhongyang Shen

6PUBLICATIONS
33CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Computer visionBiological adaptationCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 07, 2024
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1.

Fanchong Jian, Jing Wang, Ayijiang Yisimayi

|Nov 22, 2023
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.

Ayijiang Yisimayi, Weiliang Song, Jing Wang

|Dec 19, 2022
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.

Yunlong Cao, Fanchong Jian, Jing Wang

|Jun 17, 2022
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.

Yunlong Cao, Ayijiang Yisimayi, Fanchong Jian

|Apr 04, 2022
Capecitabine Regulates HSP90AB1 Expression and Induces Apoptosis via Akt/SMARCC1/AP-1/ROS Axis in T Cells.

Sai Zhang, Shunli Fan, Zhenglu Wang

|Feb 04, 2022
Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates.

Yuanyuan Du, Zhen Liang, Shusen Wang

Pageof 1